SARS Transmission Pattern in Singapore Reassessed by Viral Sequence Variation Analysis

Background Epidemiological investigations of infectious disease are mainly dependent on indirect contact information and only occasionally assisted by characterization of pathogen sequence variation from clinical isolates. Direct sequence analysis of the pathogen, particularly at a population level, is generally thought to be too cumbersome, technically difficult, and expensive. We present here a novel application of mass spectrometry (MS)–based technology in characterizing viral sequence variations that overcomes these problems, and we apply it retrospectively to the severe acute respiratory syndrome (SARS) outbreak in Singapore. Methods and Findings The success rate of the MS-based analysis for detecting SARS coronavirus (SARS-CoV) sequence variations was determined to be 95% with 75 copies of viral RNA per reaction, which is sufficient to directly analyze both clinical and cultured samples. Analysis of 13 SARS-CoV isolates from the different stages of the Singapore outbreak identified nine sequence variations that could define the molecular relationship between them and pointed to a new, previously unidentified, primary route of introduction of SARS-CoV into the Singapore population. Our direct determination of viral sequence variation from a clinical sample also clarified an unresolved epidemiological link regarding the acquisition of SARS in a German patient. We were also able to detect heterogeneous viral sequences in primary lung tissues, suggesting a possible coevolution of quasispecies of virus within a single host. Conclusion This study has further demonstrated the importance of improving clinical and epidemiological studies of pathogen transmission through the use of genetic analysis and has revealed the MS-based analysis to be a sensitive and accurate method for characterizing SARS-CoV genetic variations in clinical samples. We suggest that this approach should be used routinely during outbreaks of a wide variety of agents, in order to allow the most effective control.

[1]  J. Gaddum.  Probit Analysis , 1948, Nature.

[2]  S. Tsui,et al.  Coronavirus genomic-sequence variations and the epidemiology of the severe acute respiratory syndrome. , 2003, The New England journal of medicine.

[3]  Sung Keun Kang,et al.  Molecular evolution of the SARS coronavirus during the course of the SARS epidemic in China. , 2004, Science.

[4]  Y. Guan,et al.  Early diagnosis of SARS Coronavirus infection by real time RT-PCR , 2003, Journal of Clinical Virology.

[5]  J. Sung,et al.  Detection of SARS coronavirus in plasma by real-time RT-PCR. , 2003, The New England journal of medicine.

[6]  Y. Guan,et al.  The severe acute respiratory syndrome. , 2003, The New England journal of medicine.

[7]  Tao Zhang,et al.  Mutational dynamics of the SARS coronavirus in cell culture and human populations isolated in 2003 , 2004, BMC infectious diseases.

[8]  Obi L. Griffith,et al.  The Genome Sequence of the SARS-Associated Coronavirus , 2003, Science.

[9]  J. Lewis,et al.  Probit Analysis (3rd ed). , 1972 .

[10]  J. Sung,et al.  Quantitative Analysis and Prognostic Implication of SARS Coronavirus RNA in the Plasma and Serum of Patients with Severe Acute Respiratory Syndrome , 2003 .

[11]  A. Danchin,et al.  The Severe Acute Respiratory Syndrome , 2003 .

[12]  Charles R Cantor,et al.  A high-throughput gene expression analysis technique using competitive PCR and matrix-assisted laser desorption ionization time-of-flight MS , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[13]  A. Lazzarin,et al.  Coronaviridae and SARS-associated Coronavirus Strain HSR1 , 2004, Emerging infectious diseases.

[14]  E. Liu,et al.  Detection of Severe Acute Respiratory Syndrome Coronavirus in Blood of Infected Patients , 2004, Journal of Clinical Microbiology.

[15]  C. Hsiung,et al.  Sensitive and Quantitative Detection of Severe Acute Respiratory Syndrome Coronavirus Infection by Real-Time Nested Polymerase Chain Reaction , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[16]  L. Poon,et al.  Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia : a prospective study , 2003 .

[17]  Y. Guan,et al.  Molecular epidemiology of the novel coronavirus that causes severe acute respiratory syndrome , 2004, The Lancet.

[18]  S. Tsai,et al.  Characterization of severe acute respiratory syndrome coronavirus genomes in Taiwan: molecular epidemiology and genome evolution. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[19]  Christian Drosten,et al.  Identification of a novel coronavirus in patients with severe acute respiratory syndrome. , 2003, The New England journal of medicine.

[20]  Zheng Zhang,et al.  SARS-associated coronavirus quasispecies in individual patients. , 2004, The New England journal of medicine.

[21]  Y. Guan,et al.  Coronavirus as a possible cause of severe acute respiratory syndrome , 2003, The Lancet.

[22]  Christopher W. Wong,et al.  Tracking the evolution of the SARS coronavirus using high-throughput, high-density resequencing arrays. , 2004, Genome research.

[23]  Philip M. Long,et al.  Comparative full-length genome sequence analysis of 14 SARS coronavirus isolates and common mutations associated with putative origins of infection , 2003, The Lancet.

[24]  Christian Drosten,et al.  Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory Syndrome , 2003, Science.

[25]  Charles R Cantor,et al.  The use of MassARRAY technology for high throughput genotyping. , 2002, Advances in biochemical engineering/biotechnology.

[26]  Alexander E Gorbalenya,et al.  Mechanisms and enzymes involved in SARS coronavirus genome expression. , 2003, The Journal of general virology.

[27]  Guoping Zhao,et al.  Molecular Evolution of the SARS Coronavirus During the Course of the SARS Epidemic in China , 2004, Science.